These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. The yeast zinc finger regulators Pdr1p and Pdr3p control pleiotropic drug resistance (PDR) as homo- and heterodimers in vivo. Mamnun YM, Pandjaitan R, Mahé Y, Delahodde A, Kuchler K. Mol Microbiol; 2002 Dec; 46(5):1429-40. PubMed ID: 12453227 [Abstract] [Full Text] [Related]
13. Sensitivity to Sn2+ of the yeast Saccharomyces cerevisiae depends on general energy metabolism, metal transport, anti-oxidative defences, and DNA repair. Viau C, Pungartnik C, Schmitt MC, Basso TS, Henriques JA, Brendel M. Biometals; 2006 Dec 02; 19(6):705-14. PubMed ID: 16691319 [Abstract] [Full Text] [Related]
14. Site-directed mutagenesis of Asp853 in Pdr3p transcriptional activator from Saccharomyces cerevisiae. Dzugasova V, Borecka S, Batova M, Pilisiova R, Hervayova N, Subik J. Yeast; 2010 May 02; 27(5):277-84. PubMed ID: 20146400 [Abstract] [Full Text] [Related]
16. Clustered amino acid substitutions in the yeast transcription regulator Pdr3p increase pleiotropic drug resistance and identify a new central regulatory domain. Nourani A, Papajova D, Delahodde A, Jacq C, Subik J. Mol Gen Genet; 1997 Oct 02; 256(4):397-405. PubMed ID: 9393437 [Abstract] [Full Text] [Related]
19. YAP1 confers resistance to the fatty acid synthase inhibitor cerulenin through the transporter Flr1p in Saccharomyces cerevisiae. Oskouian B, Saba JD. Mol Gen Genet; 1999 Mar 02; 261(2):346-53. PubMed ID: 10102370 [Abstract] [Full Text] [Related]